Article(id=1304140187722870869, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1304140186485543391, articleNumber=null, orderNo=null, doi=10.7501/j.issn.0253-2670.2026.03.001, pmid=null, cstr=null, oa=null, hot=0, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=null, receivedDateStr=null, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1788860850506, onlineDateStr=2026-09-08, pubDate=null, pubDateStr=null, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1788860850506, onlineIssueDateStr=2026-09-08, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1788860850506, creator=13701087609, updateTime=1788860850506, updator=13701087609, issue=Issue{id=1304140186485543391, tenantId=1146029695717560320, journalId=1302319053441957962, year='2026', volume='57', issue='3', pageStart='789', pageEnd='1208', issueExtLink='null', onlineDate='null', pubDate='1770825600000', pubDateStr='2026-02-12', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1788860850211, creator='13701087609', updateTime=1788860942564, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1304140573955351430, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1304140186485543391, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1304140573955351431, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1304140186485543391, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=789, endPage=798, ext={EN=ArticleExt(id=1304140188138106968, articleId=1304140187722870869, tenantId=1146029695717560320, journalId=1302319053441957962, language=EN, title=Key issues and countermeasures of carbon footprint accounting for green manufacturing of traditional Chinese Medicines, columnId=null, journalTitle=Chinese Traditional and Herbal Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=Against the backdrop of global efforts to combat climate change and China’s implementation of the dual-carbon strategy (carbon peaking and carbon neutrality), advancing the green and low-carbon transition of the traditional Chinese medicine (TCM) industry represents a critical pathway toward achieving sustainable and high-quality development. Carbon footprint, as an important evaluation indicator, is crucial for the green manufacturing upgrade and international competitiveness enhancement of the TCM industry. This study systematically explores the connotation of green manufacturing of TCM and its intrinsic relationship with carbon footprint accounting. It also reviews current carbon footprint accounting policies, standards, and research advancements both domestically and internationally, particularly within the pharmaceutical sector. Based on life cycle assessment (LCA) theory and focusing on the unique characteristics of the TCM industry, this paper deeply reveals the key issues currently faced by carbon footprint accounting: weak data foundation and high uncertainty, ambiguous system boundaries and allocation rules, and the difficulty of general models in adapting to the spatio-temporal coupling characteristics of “energy-quality-efficiency” in TCM. Therefore, it is urgent to promote the localization and reconstruction of LCA theory, build a dynamic accounting model covering the entire chain from “medicinal materials-processing-preparation”, establish an industry-specific database, develop intelligent data collection technology, and promote the coordination of standard systems and policies. This research lays a theoretical foundation for constructing a novel evaluation paradigm for TCM green manufacturing-characterized by low carbon emissions, high product quality, and high operational efficiency and contributes to serving the dual-carbon strategy and the sustainable development of the TCM industry., authors=CI Zhimin, MA Hongyan, LI Zheng, YANG Ming, WANG Xuecheng, WU Zhenfeng, ZHANG Dingkun, authorsList=CI Zhimin, MA Hongyan, LI Zheng, YANG Ming, WANG Xuecheng, WU Zhenfeng, ZHANG Dingkun, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1304140188050026583, articleId=1304140187722870869, tenantId=1146029695717560320, journalId=1302319053441957962, language=CN, title=中药绿色制造碳足迹核算的关键问题与对策, columnId=1304140187961946198, journalTitle=中草药, columnName=专论, runingTitle=null, highlight=null, articleAbstract=在全球应对气候变化及我国实施“双碳”战略背景下，推动中药产业绿色低碳转型是实现其高质量发展的关键路径。碳足迹作为重要评价指标，对中药产业绿色制造升级与国际竞争力提升至关重要。系统剖析了中药绿色制造的内涵及其与碳足迹核算的内在联系，综述了国内外碳足迹核算政策、标准体系及制药领域研究进展。聚焦中药产业的特殊性，基于生命周期评价（life cycle assessment，LCA）理论，深入揭示当前碳足迹核算面临的关键问题：数据基础薄弱且不确定性高、系统边界与分配规则模糊、通用模型难以适配中药“能-质-效”时空耦合特性。为此，亟需推进LCA理论的本土化重构，构建覆盖“药材-炮制-制剂”全链条的动态核算模型，建设行业专属数据库，发展智能数据采集技术，并推动标准体系与政策协同。旨在为建立“低碳-优质-高效”融合的中药绿色制造评价新范式提供理论支撑，服务中医药产业“双碳”战略与可持续发展。, authors=慈志敏1,2 , 马鸿雁1 , 李正3 , 杨明4 , 王学成4 , 伍振峰4 , 张定堃1,2 , authorsList=慈志敏, 马鸿雁, 李正, 杨明, 王学成, 伍振峰, 张定堃, authorCompany=1 成都中医药大学西南特色中药资源国家重点实验室, 四川 成都 611137; Environ Monit Assess , 2011, 178(1/2/3/4): 135-160.et al . Advantages and drawbacks of life cycle assessment application to the pharmaceuticals: A short critical literature review [J]. Environ Sci Pollut Res Int , 2024. DOI: 10.1007/s11356-024-33964-w.Future Healthc J , 2021, 8(3): e683-e685.J Clean Prod , 2019, 214: 185-194.et al . Carbon footprint of oral medicines using hybrid life cycle assessment [J]. J Clean Prod , 2024, 475: 143576.et al . Life cycle assessment of pharmaceuticals: The ciprofloxacin hydrochloride case [J]. Int J Life Cycle Assess , 2021, 26(1): 64-75.et al . Research on waste gas treatment technology and comprehensive environmental performance evaluation for collaborative management of pollution and carbon in China’s pharmaceutical industry based on life cycle assessment (LCA) [J]. Sci Total Environ , 2024, 919: 170555.et al . Freeze drying in the biopharmaceutical industry: An environmental sustainability assessment [J]. Food Bioprod Process , 2019, 117: 213-223.et al . Case study on carbon emission of a traditional Chinese medicine pharmaceutical enterprise toward carbon neutrality [J]. J Clean Prod , 2024, 450: 141600.et al . Green solvent: Green shadow on chemical synthesis [J]. Curr Org Synth , 2020, 17(6): 426-439.et al . Cradle-to-gate greenhouse gas emissions for twenty anesthetic active pharmaceutical ingredients based on process scale-up and process design calculations [J]. ACS Sustainable Chem Eng , 2019, 7(7): 6580-6591.2 净交换估算 [J]. 科学通报, 2004, 49(3): 258-264.
中草药
|专论
2026
, 57
(3) :
789
-798
中药绿色制造碳足迹核算的关键问题与对策
全屏
慈志敏1,2 , 马鸿雁1 , 李正3 , 杨明4 , 王学成4 , 伍振峰4 , 张定堃1,2
作者信息
1 成都中医药大学西南特色中药资源国家重点实验室, 四川 成都 611137;
通讯作者:
伍振峰
作者简介:
慈志敏: 慈志敏，讲师，从事中药制药工程与绿色制造新技术研究。E-mail:zmci@cdutcm.edu.cn
Key issues and countermeasures of carbon footprint accounting for green manufacturing of traditional Chinese Medicines
CI Zhimin, MA Hongyan, LI Zheng, YANG Ming, WANG Xuecheng, WU Zhenfeng, ZHANG Dingkun
Affiliations
doi: 10.7501/j.issn.0253-2670.2026.03.001
文章导航
在全球应对气候变化及我国实施“双碳”战略背景下，推动中药产业绿色低碳转型是实现其高质量发展的关键路径。碳足迹作为重要评价指标，对中药产业绿色制造升级与国际竞争力提升至关重要。系统剖析了中药绿色制造的内涵及其与碳足迹核算的内在联系，综述了国内外碳足迹核算政策、标准体系及制药领域研究进展。聚焦中药产业的特殊性，基于生命周期评价（life cycle assessment，LCA）理论，深入揭示当前碳足迹核算面临的关键问题：数据基础薄弱且不确定性高、系统边界与分配规则模糊、通用模型难以适配中药“能-质-效”时空耦合特性。为此，亟需推进LCA理论的本土化重构，构建覆盖“药材-炮制-制剂”全链条的动态核算模型，建设行业专属数据库，发展智能数据采集技术，并推动标准体系与政策协同。旨在为建立“低碳-优质-高效”融合的中药绿色制造评价新范式提供理论支撑，服务中医药产业“双碳”战略与可持续发展。
中药绿色制造
/
碳足迹
/
生命周期评价
/
数据融合
/
系统边界
/
核算模型
Against the backdrop of global efforts to combat climate change and China’s implementation of the dual-carbon strategy (carbon peaking and carbon neutrality), advancing the green and low-carbon transition of the traditional Chinese medicine (TCM) industry represents a critical pathway toward achieving sustainable and high-quality development. Carbon footprint, as an important evaluation indicator, is crucial for the green manufacturing upgrade and international competitiveness enhancement of the TCM industry. This study systematically explores the connotation of green manufacturing of TCM and its intrinsic relationship with carbon footprint accounting. It also reviews current carbon footprint accounting policies, standards, and research advancements both domestically and internationally, particularly within the pharmaceutical sector. Based on life cycle assessment (LCA) theory and focusing on the unique characteristics of the TCM industry, this paper deeply reveals the key issues currently faced by carbon footprint accounting: weak data foundation and high uncertainty, ambiguous system boundaries and allocation rules, and the difficulty of general models in adapting to the spatio-temporal coupling characteristics of “energy-quality-efficiency” in TCM. Therefore, it is urgent to promote the localization and reconstruction of LCA theory, build a dynamic accounting model covering the entire chain from “medicinal materials-processing-preparation”, establish an industry-specific database, develop intelligent data collection technology, and promote the coordination of standard systems and policies. This research lays a theoretical foundation for constructing a novel evaluation paradigm for TCM green manufacturing-characterized by low carbon emissions, high product quality, and high operational efficiency and contributes to serving the dual-carbon strategy and the sustainable development of the TCM industry.
TCM green manufacturing
/
carbon footprint
/
life cycle assessment
/
data fusion
/
system boundary
/
accounting model
慈志敏, 马鸿雁, 李正, 杨明, 王学成, 伍振峰, 张定堃.
中药绿色制造碳足迹核算的关键问题与对策.
中草药,
2026
, 57
(3)
: 789
-798
.
DOI: 10.7501/j.issn.0253-2670.2026.03.001
CI Zhimin, MA Hongyan, LI Zheng, YANG Ming, WANG Xuecheng, WU Zhenfeng, ZHANG Dingkun.
Key issues and countermeasures of carbon footprint accounting for green manufacturing of traditional Chinese Medicines[J].
Chinese Traditional and Herbal Drugs ,
2026
, 57
(3)
: 789
-798
.
DOI: 10.7501/j.issn.0253-2670.2026.03.001
参考文献
引证文献
国家发展改革委等关于《完善碳排放统计核算体系工作方案》的通知 [EB/OL]. (2024-10-08) [2025-07-10]. https://www.gov.cn/zhengce/zhengceku/202410/content_6983052.htm.Environ Monit Assess , 2011, 178(1/2/3/4): 135-160.et al . Advantages and drawbacks of life cycle assessment application to the pharmaceuticals: A short critical literature review [J]. Environ Sci Pollut Res Int , 2024. DOI: 10.1007/s11356-024-33964-w.Future Healthc J , 2021, 8(3): e683-e685.J Clean Prod , 2019, 214: 185-194.et al . Carbon footprint of oral medicines using hybrid life cycle assessment [J]. J Clean Prod , 2024, 475: 143576.et al . Life cycle assessment of pharmaceuticals: The ciprofloxacin hydrochloride case [J]. Int J Life Cycle Assess , 2021, 26(1): 64-75.et al . Research on waste gas treatment technology and comprehensive environmental performance evaluation for collaborative management of pollution and carbon in China’s pharmaceutical industry based on life cycle assessment (LCA) [J]. Sci Total Environ , 2024, 919: 170555.et al . Freeze drying in the biopharmaceutical industry: An environmental sustainability assessment [J]. Food Bioprod Process , 2019, 117: 213-223.et al . Case study on carbon emission of a traditional Chinese medicine pharmaceutical enterprise toward carbon neutrality [J]. J Clean Prod , 2024, 450: 141600.et al . Green solvent: Green shadow on chemical synthesis [J]. Curr Org Synth , 2020, 17(6): 426-439.et al . Cradle-to-gate greenhouse gas emissions for twenty anesthetic active pharmaceutical ingredients based on process scale-up and process design calculations [J]. ACS Sustainable Chem Eng , 2019, 7(7): 6580-6591.2 净交换估算 [J]. 科学通报, 2004, 49(3): 258-264.
2026年第57卷第3期
PDF下载
30
7
引用本文
BibTeX
文章信息
doi: 10.7501/j.issn.0253-2670.2026.03.001
https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.03.001
引用本文
BibTeX
2种不同金属材料的力学参数
科 属数 种数 占总种数比例 属 种数 占总种数比例 鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78 小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39 多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39 红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87 小菇属 Mycena 11 5.26 光柄菇属 Pluteus 5 2.39 红菇属 Russula 17 8.13 栓菌属 Trametes 5 2.39
关闭全屏
BibTeX
EndNote
RefWorks
TxT
PDF下载
全屏
30
7
关闭全屏
北京市海淀区学院南路86号
010-62199257（仅加盟咨询）
qkjq@cast.org.cn
